Regulation by PGE2 of the production of oxygen intermediates by LPS-activated macrophages.
Open Access
- 1 September 1981
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 127 (3) , 1109-1113
- https://doi.org/10.4049/jimmunol.127.3.1109
Abstract
The regulation by prostaglandin E2 (PGE2) of production of oxygen radicals by bacterial lipopolysaccharide-(LPS) activated macrophages was studied in vitro. A 48-hr incubation of murine thioglycollate-elicited macrophages with LPS (0.1 micrograms/ml) resulted in an enhanced ability of these cells to produce oxygen radicals when challenged with phorbol myristate acetate (PMA). Macrophages incubated for 48 hr without LPS did not produce measurable amounts of oxygen radicals when exposed to this triggering stimulus. Thus, PMA-triggered production of oxygen radicals was the result of macrophage activation by LPS. The PMA-triggered production of oxygen radicals by the LPS-activated macrophages was inhibited when PGE2 (10(-5) to 10(-9) M) was present during the incubation with LPS. Inhibition by PGE2 occurred during the early stages of macrophage activation, since the addition of PGE2 24 hr after LPS no longer inhibited the production of oxygen radicals by the macrophages. This inhibitory effect of PGE2 on the LPS-induced activation of macrophages could be reproduced by cyclic-adenosine-monophosphate (cAMP) agonists, such as isoproterenol and cholera toxin as well as by the cAMP analog dibutyryl-cAMP, suggesting a cAMP-mediated mechanism for the inhibitory effect of PGE2 on macrophage activation by LPS. Previous reports have implicated prostaglandins as mediators of destructive processes associated with chronic inflammation. Our findings suggest that PGE2 may, on the other hand, reduce tissue damage in a chronic inflammatory site by inhibiting the production of oxygen radicals by macrophages activated in the sera.This publication has 21 references indexed in Scilit:
- Macrophage Migration Inhibition Factor: Interactions with Calcium, Magnesium, and Cyclic AMPThe Journal of Immunology, 1978
- Increased superoxide anion production by immunologically activated and chemically elicited macrophagesThe Journal of Experimental Medicine, 1978
- Effect of anti-inflammatory drugs and agents that elevate intracellular cyclic AMP on the release of toxic oxygen metabolites by phagocytes: Studies in a model of tissue-bound IgGClinical Immunology and Immunopathology, 1978
- Oxygen-Dependent Microbial Killing by PhagocytesNew England Journal of Medicine, 1978
- INHIBITION OF PLASMINOGEN ACTIVATOR SECRETION BY CYCLIC-AMP IN A MACROPHAGE-LIKE CELL LINE1978
- Prostaglandin regulation of macrophage collagenase production.Proceedings of the National Academy of Sciences, 1977
- The mechanism of action of soluble lymphocyte mediatorsCellular Immunology, 1977
- Effect of isoproterenol and aminophylline on cyclic AMP levels of guinea pig macrophagesCellular Immunology, 1976
- Macrophage plasminogen activator: Modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotidesCell, 1976
- The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes.Journal of Clinical Investigation, 1975